Nievas I Federico Fernandez, Anand Kanwaljeet J S
Departments of Pediatrics, Anesthesiology, Anatomy & Neurobiology, Division of Critical Care Medicine, University of Tennessee Health Science Center, and Le Bonheur Children's Hospital, Memphis, Tennessee.
J Pediatr Pharmacol Ther. 2013 Apr;18(2):88-104. doi: 10.5863/1551-6776-18.2.88.
An increasing prevalence of pediatric asthma has led to increasing burdens of critical illness in children with severe acute asthma exacerbations, often leading to respiratory distress, progressive hypoxia, and respiratory failure. We review the definitions, epidemiology, pathophysiology, and clinical manifestations of severe acute asthma, with a view to developing an evidence-based, stepwise approach for escalating therapy in these patients.
Subject headings related to asthma, status asthmaticus, critical asthma, and drug therapy were used in a MEDLINE search (1980-2012), supplemented by a manual search of personal files, references cited in the reviewed articles, and treatment algorithms developed within Le Bonheur Children's Hospital.
Patients with asthma require continuous monitoring of their cardiorespiratory status via noninvasive or invasive devices, with serial clinical examinations, objective scoring of asthma severity (using an objective pediatric asthma score), and appropriate diagnostic tests. All patients are treated with β-agonists, ipratropium, and steroids (intravenous preferable over oral preparations). Patients with worsening clinical status should be progressively treated with continuous β-agonists, intravenous magnesium, helium-oxygen mixtures, intravenous terbutaline and/or aminophylline, coupled with high-flow oxygen and non-invasive ventilation to limit the work of breathing, hypoxemia, and possibly hypercarbia. Sedation with low-dose ketamine (with or without benzodiazepines) infusions may allow better toleration of non-invasive ventilation and may also prepare the patient for tracheal intubation and mechanical ventilation, if indicated by a worsening clinical status.
Severe asthma can be a devastating illness in children, but most patients can be managed by using serial objective assessments and the stepwise clinical approach outlined herein. Following multidisciplinary education and training, this approach was successfully implemented in a tertiary-care, metropolitan children's hospital.
小儿哮喘患病率不断上升,导致重度急性哮喘发作患儿的危重症负担加重,常引发呼吸窘迫、进行性缺氧和呼吸衰竭。我们回顾了重度急性哮喘的定义、流行病学、病理生理学和临床表现,以期制定一种基于证据的、逐步升级治疗这些患者的方法。
在MEDLINE数据库(1980 - 2012年)中检索与哮喘、哮喘持续状态、重症哮喘和药物治疗相关的主题词,并辅以人工查阅个人文件、所评论文中引用的参考文献以及勒博内尔儿童医院制定的治疗算法。
哮喘患者需要通过无创或有创设备持续监测其心肺状态,进行系列临床检查、对哮喘严重程度进行客观评分(使用客观小儿哮喘评分)以及进行适当的诊断测试。所有患者均接受β受体激动剂、异丙托溴铵和类固醇治疗(静脉用药优于口服制剂)。临床状态恶化的患者应逐步接受持续β受体激动剂、静脉注射镁剂、氦氧混合气、静脉注射特布他林和/或氨茶碱治疗,同时给予高流量氧气和无创通气,以减轻呼吸做功、纠正低氧血症,并可能改善高碳酸血症。低剂量氯胺酮(加或不加苯二氮䓬类药物)静脉输注镇静可能使患者更好地耐受无创通气,并且如果临床状态恶化表明有必要,还可为气管插管和机械通气做好准备。
重度哮喘对儿童来说可能是一种毁灭性疾病,但大多数患者可以通过使用系列客观评估和本文所述的逐步临床方法进行管理。经过多学科教育和培训后,这种方法在一家大都市三级儿童专科医院成功实施。